- New round of grants set to attract more interstate and international biomedical projects to Queensland
- Funding will support the financial costs of developing new biomedical products locally
- Applications for funding of up to $250,000 for eligible projects opens today, 6 March 2024
A new round of Biomedical grants is set to attract projects from far and wide to Queensland.
The Queensland Biomedical Business Attraction Program (QBBAP) will provide up to $1.5 million in grants for eligible Queensland-based entities to develop a biomedical product, with each receiving up to $250,000.
The funding will further raise awareness of Queensland’s world-class biomedical sector capabilities.
This is the fourth QBBAP funding round and previous recipients include:
- Microba, a microbiome research support company, are using their grant to provide clinical study services to an international client. This has helped them attract new clients in the in the emerging field of microbiome-targeting therapies, which play a key role in many aspects of health and disease.
- UQ attracted national and international clients to its state-of-the-art laboratories providing custom manufacturing solutions to develop next generation complex therapies e.g. protecting pets and livestock from paralysis tick toxins.
- AnteoTech entered an agreement with an international company for the joint production and marketing of a novel diagnostic solution.
- The Queensland University of Technology was conducted a preclinical study for its interstate client in the development of a type 1 diabetes treatment.
- Patheon Biologics, which manufactures complex innovative drugs from cells, secured a new international client through the grant.
Quotes attributable to Minister for State Development and Infrastructure Grace Grace:
“This new round of grants will ensure more world-class biomedical projects will come to Queensland.
“The Queensland Biomedical Business Attraction Program assists our Queensland-based entities by providing grants equal to up to one-third of the service costs of developing a biomedical product here.
“We want our locally based entities to start thinking about which interstate and international clients they can partner with to bring exciting new projects here to the Sunshine State.
“This initiative will help spread the word about Queensland’s biomedical skills, services and facilities and assist us to play a bigger role in meeting global health challenges.”
